Lv2
110 积分 2026-05-04 加入
Symptoms and treatment response to florensocatib and inhaled tobramycin in bronchiectasis: Post hoc analysis of two randomized trials
3天前
已完结
Bacterial load, respiratory symptoms and inhaled antibiotic treatment in adults with bronchiectasis: a post hoc analysis of the TORNASOL trial
3天前
已关闭
The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia
13天前
已完结
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials
13天前
已完结
Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrine
13天前
已完结
Efficacy and Safety of Ensifentrine in Chinese Patients With COPD
13天前
已完结
Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease
13天前
已完结
Ensifentrine: First Approval
13天前
已完结
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)
13天前
已完结
Familial hyperaldosteronism Type II in a pediatric patient: diagnostic and multidisciplinary challenges
18天前
已关闭
皖公网安备34019202002308
